Banner Image

Trends, Insights & Analysis

Prescription Drug News of Note - May 2018

May 31, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - April 2018

Apr 27, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

4 Ways to Tell a Copay Program Vendor from a Copay Program Partner

Apr 16, 2018 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs, Patient Access Programs
Who's at the table for your brand planning sessions?
Read more ▸▸

What Princess Is Your Copay Program?

Apr 3, 2018 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs, Patient Access Programs
If your copay program is underwater, it might be Ariel.
Read more ▸▸

Making Sense of Benefit M&A

Mar 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Pharmacy Benefit Managers
With recent mergers like the Cigna/Express Scripts (ESI) deal, stakeholders across the pharmaceutical industry are curious about the future of independent PBMs, the future of pharmacy carve-out, the opportunity for Truveris, and if/how Amazon can be a catalyst to a major change in the way that we experience, and pay for, healthcare.
Read more ▸▸

Prescription Drug News of Note - March 2018

Mar 27, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - February 2018

Feb 27, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approvals, Prescription spending trends, and the latest on Albertson's and Rite Aid
Read more ▸▸

Deductibles and the Consumerization of Healthcare: What Does it Mean for Biopharma Brands?

Feb 7, 2018 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Access Programs
As consumers are gaining more control over their healthcare spend, here’s what biopharma brands need to consider.
Read more ▸▸

2018 Specialty Drug Trends: What Employers Should Expect

Jan 30, 2018 | Trends, Insights & Analysis, Enterprise Employers, Pharmacy Benefit Managers
Specialty drugs are expensive for employers paying for prescription benefit plans. Learn how to lower costs in 2018 with specialty drug management strategies.
Read more ▸▸

Prescription Drug News of Note - January 2018

Jan 26, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approves 46 Novel Medications in 2017, Hospitals to Start Their Own Generic Drug Company
Read more ▸▸

Is Cutting Costs on Your Copay Program Costing You?

Jan 22, 2018 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
The long term costs of your copay program’s patient benefit often outweigh the upfront costs of program administrative fees. Here’s what to watch out for.
Read more ▸▸

PBM Contracts: 7 Terms Employers Need to Know

Jan 12, 2018 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Pharmacy Benefit Managers
PBM contracts can be confusing and packed with jargon. Here’s what employers need to know to navigate their pharmacy benefits.
Read more ▸▸

5 Dos and Don’ts in Your New Copay Program’s First Weeks

Jan 5, 2018 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
The new year means a new copay program for many brand managers. Here are a few things to think about as you watch the results from your copay program come in.
Read more ▸▸

Your Cheat Sheet for Pharmacy Benefits

Dec 26, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Pharmacy Benefit Managers
Pharmacy benefits can be confusing, with many moving parts. Our cheat sheet breaks down what you need to know to become wiser in the area of pharmacy benefits.
Read more ▸▸

Top 4 Myths of Pharmacy Benefits

Dec 26, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Pharmacy Benefit Managers
When it comes to pharmacy benefits, there's a lot of information out there — and a lot of misinformation. We present and debunk 4 myths about pharmacy benefits.
Read more ▸▸

Prescription Drug News of Note - December 2017

Dec 25, 2017 | Trends, Insights & Analysis
Each month, we round up the latest FDA approvals and regulations... FDA approves Lyrica CR capsules, Imprimis Pharmaceuticals announces alternative to Restasis
Read more ▸▸

Six Best Practices for Working with Self-Insured Businesses

Dec 20, 2017 | Trends, Insights & Analysis, Brokers, Pharmacy Benefit Managers
What advice can brokers give to their self-insured clients? Here are six best-practices for helping self-insured clients control costs and mitigate risk.
Read more ▸▸

Why collecting patient data may be the best thing for your brand

Dec 18, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Access Programs
When done correctly, collecting patient data can have a big impact on your brand. Here’s how to do it well.
Read more ▸▸

Three Ways to Enhance Your Patient Engagement Strategy

Dec 12, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Access Programs
Your pharmaceutical CRM has huge potential to drive patient engagement and lower abandonment rates. Targeted, timely messaging is the key to success.
Read more ▸▸

Pharmacy Carve Out: Why it Makes Sense for Employers

Nov 28, 2017 | Trends, Insights & Analysis, Enterprise Employers, Brokers, Pharmacy Carve Out
Thinking about carving out your company’s pharmacy benefits? Here’s why a pharmacy carve-out might be right for your company.
Read more ▸▸

Prescription Drug News of Note - November 2017

Nov 28, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations... FDA approves Lyrica CR capsules, Imprimis Pharmaceuticals announces alternative to Restasis
Read more ▸▸

3 Ways to Use Copay Program Data to Reach Physicians

Nov 20, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
Copay program data can help your brand succeed in the physician’s office. Learn more on the Truveris blog.
Read more ▸▸

What is a Pharmacy Carve Out Plan?

Nov 14, 2017 | Trends, Insights & Analysis, Enterprise Employers, Brokers, Pharmacy Carve Out
Employers are turning to pharmacy carve out plans as a solution to rising prescription drug costs. Here’s your primer on carving out pharmacy benefits.
Read more ▸▸

Truveris Ranks on Deloitte's 2017 #Fast500 List of Fastest-Growing Technology Companies

Nov 9, 2017 | Trends, Insights & Analysis
Deloitte announced that Truveris is one of the fastest growing technology companies in North America, reaching #205 on their annual Technology Fast 500 list.
Read more ▸▸

Six Places Your Copay Program can Provide Deeper Insights and Drive Success

Oct 30, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
Your copay program is generating a wealth of data, but do you know how and where to use it?
Read more ▸▸

What Anthem's new PBM, IngenioRx means for Brokers and Employers

Oct 23, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Pharmacy Benefit Managers
Anthem, Inc. announced that it is establishing a new pharmacy benefits manager (PBM) named IngenioRx. What does this mean for employers and brokers?
Read more ▸▸

California’s Copay Coupon Bill Stirs Up Panic—Here’s What Pharmaceutical Brand Teams Need To Know.

Oct 16, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Prescription Drug News & Regulations - Pharma
How to navigate California's AB-265, a bill designed to curb the use of copay coupons for branded prescription drugs when a generic version is available.
Read more ▸▸

Prescription Drug News of Note - October 2017

Oct 15, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Is Your Patient Abandonment Rate Really What You Think it is?

Oct 2, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Abandonment
Determining your brand’s true patient abandonment rate starts with understanding the data from key steps along the patient journey.
Read more ▸▸

How Artificial Intelligence in Healthcare is Helping Physicians Better Prescribe Treatments

Sep 21, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Medicine & Technology
The growing use of AI in healthcare is leading to more effective individualized treatments and greater patient access.
Read more ▸▸

Prescription Drug News of Note - September 2017

Sep 11, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Top 5 Copay Program Fallacies

Sep 8, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
There are many common misconceptions associated with designing or managing your copay program. Don’t be fooled by them, as they are likely hindering your performance.
Read more ▸▸

Is Your Copay Program Ready For 2018?

Aug 24, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
It’s after Labor Day and you have spent the summer carefully brand planning and strategically evaluating the tactics you need to put in place for 2017.
Read more ▸▸

Are You Considering The Right Segmentation Options For Your Copay Program?

Aug 24, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
When it comes to designing your copay program, chances are you haven’t considered all of the options.
Read more ▸▸

What is a Pharmacy Benefit Manager (PBM) and how Does a PBM Impact the Pharmacy Benefits Ecosystem?

Aug 15, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Pharmacy Benefit Managers
Pharmacy Benefits Managers play an important and often complicated role in the prescription benefits industry. Learn more on the Truveris blog.
Read more ▸▸

Is Your Copay Program Costing You More Than It’s Earning? Keep These Top 5 Metrics In Mind

Aug 11, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
While the strategy and goals of every copay program vary, we’ve found that the top 5 essential metrics to track ROI stay the same.
Read more ▸▸

Prescription Drug News of Note – August 2017

Aug 1, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
A rundown of the latest FDA approvals and regulations from August 2017, with an expert take on what you need to know in the prescription drug industry.
Read more ▸▸

The Keys To A Successful Partnership

Dec 12, 2016 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Access Programs
Use these five tips to create a productive relationship with your partner to ensure your copay program’s success.
Read more ▸▸

The Single Question You Are Missing From Your RFP

Nov 16, 2016 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Access Programs
Selecting the right strategic partner can be a challenge and a Request for Proposal (RFP) is an important part of the selection process.
Read more ▸▸

How Can 340B Pricing Help Healthcare Organizations Save On Medications?

May 25, 2016 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Prescription Drug News & Regulations - Pharma
As prescription drug prices continue to increase, consumers are finding it increasingly difficult to pay for their medications.
Read more ▸▸

10 Questions Employers Should Be Asking About the Cadillac Tax

Apr 20, 2016 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
The Cadillac Tax is an excise tax levied on employers that provide high-cost health benefit plans to their employees.
Read more ▸▸

What Is A Single Source Generic And How Does It Impact Drug Pricing?

Apr 7, 2016 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Drug Pricing
Before signing up for any new insurance plan, you should familiarize yourself with an often overlooked segment of insurance – your pharmacy benefits plan.
Read more ▸▸

Exploring the Price of Medication

Mar 29, 2016 | Trends, Insights & Analysis, Consumers, Drug Pricing
Drug prices have increased dramatically over the past decade. But only 17 percent of consumers shop around for drugs to see if they can get better deal.
Read more ▸▸

How Do Genes Affect Drug Response?

Mar 16, 2016 | Trends, Insights & Analysis, Consumers, Medicine & Technology
Have you ever wondered why some medications work for certain people but not others? Why might you experience side effects from a drug while your friend doesn’t?
Read more ▸▸

3 Novel Ways Medication May Impact Your Health

Mar 1, 2016 | Trends, Insights & Analysis, Consumers, Medicine & Technology
Drugs affect everyone differently. So when you’re prescribed a medication, what factors dictate how it will impact your health?
Read more ▸▸